Immunosuppressive drugs inhibit the production of interleukin-6 and interleukin-8 in cultured cardiac myxoma cells

Research Communications in Molecular Pathology and Pharmacology

Volumn 97, Issue 1, 1997, Pages 60-66

  Sakamoto, Hironosuke ^a   Sakamaki, Tetsuo ^a   Kanda, Tsugiyasu ^a   Hirao, Yoshio ^a   Ohyama, Yoshio ^a   Ogishi, Koichi ^a   Negishi, Mitsuko ^a   Masuda, Hiroaki ^a   Sumino, Hiroyuki ^a   Sawada, Yoshie ^a   Ono, Zenpei ^a   Kobayashi, Isao ^a   Nagai, Ryozo ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; CYCLOSPORIN A; DEXAMETHASONE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 6; INTERLEUKIN 8; TACROLIMUS;

ADULT; AGED; ARTICLE; CASE REPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEART MYXOMA; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; TUMOR CELL CULTURE;

AGED; FEMALE; HEART NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-6; INTERLEUKIN-8; KINETICS; MALE; MIDDLE AGED; MYXOMA; TUMOR CELLS, CULTURED;

EID: 0030854864     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bataille, R., Barlogie, B., Lu, Z.Y., Rossi, J.F., Lavabre-Bertrand, T., Beck, T., Wijdens, J., Brochier, J., and Klein, B. (1995) Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma. Blood 86: 685-691.
2. Beck, J.T., Hsu, S.M., Wijdenes, J., Bataille, R., Klein, B., Vesole, D., Hayden, K., Jagannath, S., and Barlogie, B. (1994). Alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N. Engl. J. Med. 330: 602-605.
3. Boussen, K., Moalla, M., Blondeau, P., Ben-Ayed, H., and Lie, J.T. (1991) Embolization of cardiac myxomas masquerading as polyarteritis nodosa. J. Rheumatol. 18: 283-285.
4. Cohen, T., Nahari, D., Cerem, L.W., Neufeld, G., and Levi, B.Z. (1996) Interleukin-6 induces the expression of vascular endothelial growth factor. J. Biol. Chem. 271: 736-741.
5. Kanda, T., Sakamoto, H., McManus, B.M., Sakamaki, T., Nagai, R., Suzuki, T., and Kobayashi, I. (1996). Interleukin-6 secreted from human myxoma reduces murine viral myocarditis. Life Sci. 58: 1905-1912.
6. Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., Kuramoto, A., and Kishimoto, T. (1988) Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332: 83-85.
7. Koch, A.E., Polverini, P.J., Kunkel, S.L., Harlow, L.A., DiPietro, L.A., Elner, V.M., Elner, S.G., and Strieter, R.M. (1992) Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258: 1798-1801.
8. McCarthy, P.M., Piehler, J.M., Schaff, H.V., Pluth, J.R., Orszulak, T.A., Vidaillet, H.J.Jr., and Carney, J.A. (1986) The significance of multiple, recurrent, and "complex" cardiac myxomas. J. Thorac. Cardiovasc. Surg. 91: 389-396.
9. Reynen, K. (1995). Cardiac myxomas. N. Engl. J. Med. 333: 1610-1617.
10. Sakamoto, H., Sakamaki, T., Wada, A., Nakajima, T., Kanda, T., and Murata, K. (1994). Dexamethasone inhibits production of interleukin-6 by cultured cardiac myxoma cells. Am. Heart J. 127: 704-705.
11. Singh, R. K., Gutman, M., Radinsky, R., Bucana, C. D., and Fidler, I.J. (1994) Expression of interleukin-8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res. 54: 3242-3247.
12. Tobler, A., Meier, R., Seitz, M., Dewald, B., Baggiolini, M., and Fey, M.F. (1992). Glucocorticoids down-regulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts. Blood 79: 45-51.
13. Wada, A., Kanda, T., Hayashi, R., Imai, S., Suzuki, T., and Murata, K. (1993). Cardiac myxoma metastasized to the brain: potential role of endogenous interleukin-6. Cardiology 83: 208-211.